AKT1 and diffuse large B-cell lymphoma: We determined the activation of PI3K/AKT pathway in DLBCL cells with different miR-27b expressions, and found a significant inhibition of the activation of PI3K/AKT pathway in DLBCL cells with miR-27b over-expression.